Botulinum toxin A does not alter capsaicin-induced pain perception in human skin

Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia

2000 • 1,715 citations

Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25

1993 • 1,200 citations

Subcutaneous administration of botulinum toxin A reduces formalin-induced pain

2003 • 652 citations

Pharmacologic weakening of extraocular muscles.

1973 • 487 citations

Sensitivity of embryonic rat dorsal root ganglia neurons to Clostridium botulinum neurotoxins

2000 • 474 citations

Botulinum Toxin A for Axillary Hyperhidrosis (Excessive Sweating)

2001 • 450 citations

Double‐blind, placebo‐controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis

1990 • 303 citations

Botulinum toxin A and chronic low back pain

2001 • 295 citations

Different patterns of hyperalgesia induced by experimental inflammation in human skin

1994 • 285 citations

A new method to increase nociception specificity of the human blink reflex

2000 • 273 citations

Botulinum toxin (Dysport(R)) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study

2000 • 238 citations

Presynaptic Effects of Botulinum Toxin Type A on the Neuronally Evoked Response of Albino and Pigmented Rabbit Iris Sphincter and Dilator Muscles

2000 • 214 citations

Low-dose lidocaine reduces secondary hyperalgesia by a central mode of action

2000 • 210 citations

Plasma extravasation and neuropeptide release in human skin as measured by intradermal microdialysis

1997 • 180 citations

Botulinum toxin A and the cutaneous nociception in humans: A prospective, double-blind, placebo-controlled, randomized study

2002 • 124 citations

Botulinum A toxins: units versus units

1997 • 110 citations

A randomized, double-blind, placebo controlled study on analgesic effects of botulinum toxin A

2003 • 100 citations

Botulinum toxin A in the treatment of headache syndromes and pericranial pain syndromes

2001 • 93 citations

Botulinum Toxin A reduces neurogenic flare but has almost no effect on pain and hyperalgesia in human skin

2003 • 85 citations

Efficacy and safety of a standardised 500 unit dose of Dysport ® (Clostridium botulinum toxin type A haemaglutinin complex) in a heterogeneous cervical dystonia population: results of a prospective, multicentre, randomised, double-blind, placebo-controlled, parallel group study

2001 • 84 citations

Reduktion von Schmerzen und Muskelanspannung durch Botulinum-Toxin A

2001 • 25 citations

Clostridial Neurotoxins

2000 • 10 citations

Exogenous zinc ion is required for inhibitory activity of botulinum neurotoxin C1 against norepinephrine release and its endopeptidase activity toward substance P.

1994 • 10 citations